Effects of grape seed proanthocyanidin extract on menopausal symptoms, body composition, and cardiovascular parameters in middle-aged women: A randomized, double-blind, placebo-controlled pilot study

Menopause

Volumn 21, Issue 9, 2014, Pages 990-996

  Terauchi, Masakazu ^a   Horiguchi, Noe ^a   Kajiyama, Asuka ^a   Akiyoshi, Mihoko ^a   Owa, Yoko ^a   Kato, Kiyoko ^a   Kubota, Toshiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antioxidants; Anxiety; Catechin; Flavonoids; Hot flashes; Hypertension; Insomnia; Polyphenols; Sarcopenia

Indexed keywords

GRAPE SEED EXTRACT; GRAVINOL; PLACEBO; PROANTHOCYANIDIN; UNCLASSIFIED DRUG; ANTIOXIDANT; VEGETABLE OIL;

ADULT; ARTICLE; ATHENS INSOMNIA SCALE; BLOOD PRESSURE REGULATION; BODY COMPOSITION; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOT FLUSH; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENOPAUSAL HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE; MENOPAUSAL SYNDROME; MIDDLE AGED; MUSCLE MASS; PILOT STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DOSE RESPONSE; HOT FLASHES; LYTHRACEAE; MENOPAUSE; PLANT SEED; TREATMENT OUTCOME;

ADULT; ANTIOXIDANTS; BLOOD PRESSURE; BODY COMPOSITION; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PILOT PROJECTS; PLANT OILS; PROANTHOCYANIDINS; PUNICACEAE; SEEDS; TREATMENT OUTCOME;

EID: 84906937359     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000200     Document Type: Article

References (34)

1. Nelson HD. Menopause. Lancet 2008;371:760-770.
2. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
3. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18.
4. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol 2009;169:1352-1361.
5. Taddei S. Blood pressure through aging and menopause. Climacteric 2009;12(suppl 1):36-40.
6. Brand JS, van der Schouw YT, Onland-Moret NC, et al. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. Diabetes Care 2013;36:1012-1019.
7. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
8. Ettinger B, Wang SM, Leslie RS, et al. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 2012;19:610-615.
9. Brett KM, Keenan NL. Complementary and alternative medicine use among midlife women for reasons including menopause in the United States: 2002. Menopause 2007;14:300-307.
10. van der Sluijs CP, Bensoussan A, Liyanage L, Shah S. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007;14:397-403.
11. Dixon RA, Xie DY, Sharma SB. Proanthocyanidins-a final frontier in flavonoid research? New Phytol 2005;165:9-28.
12. Yang HM, Liao MF, Zhu SY, Liao MN, Rohdewald P. A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women. Acta Obstet Gynecol Scand 2007;86:978-985.
13. Errichi S, Bottari A, Belcaro G, et al. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. Panminerva Med 2011;53(suppl 1):65-70.
14. Kohama T, Negami M. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial. J Reprod Med 2013;58:39-46.
15. Weber HA, Hodges AE, Guthrie JR, et al. Comparison of proanthocyanidins in commercial antioxidants: grape seed and pine bark extracts. J Agric Food Chem 2007;55:148-156.
16. Terauchi M, Obayashi S, Akiyoshi M, Kato K, Matsushima E, Kubota T. Insomnia in Japanese peri- and postmenopausal women. Climacteric 2010;13:479-486.
17. Terauchi M, Obayashi S, Akiyoshi M, Kato K, Matsushima E, Kubota T. Effects of oral estrogen and hypnotics on Japanese peri- and postmenopausal women with sleep disturbance. J Obstet Gynaecol Res 2011;37:741-749.
18. Terauchi M, Akiyoshi M, Owa Y, Kato K, Obayashi S, Kubota T. Effects of the Kampo medication keishibukuryogan on blood pressure in perimenopausal and postmenopausal women. Int J Gynecol Obstet 2011;114: 149-152.
19. Terauchi M, Hiramitsu S, Akiyoshi M, et al. Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Arch Gynecol Obstet 2011;284:913-921.
20. Terauchi M, Hiramitsu S, Akiyoshi M, et al. Associations between anxiety, depression and insomnia in peri- and post-menopausal women. Maturitas 2012;72:61-65.
21. Terauchi M, Hiramitsu S, Akiyoshi M, et al. Associations among depression, anxiety and somatic symptoms in peri- and postmenopausal women. J Obstet Gynaecol Res 2013;39:1007-1013.
22. Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986;8:217-228.
23. Hunter M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992;14:117-126.
24. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
25. Zigmond AS, Snaith RP, Kitamura T. The Hospital Anxiety and Depression Scale (in Japanese). Seisinka-Sindangaku 1993;4:371-372.
26. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000;48:555-560.
27. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res 2003;55:263-267.
28. Moreira EL, Rial D, Duarte FS, et al. Central nervous system activity of the proanthocyanidin-rich fraction obtained from Croton celtidifolius in rats. J Pharm Pharmacol 2010;62:1061-1068.
29. Pajuelo D, Díaz S, Quesada H, et al. Acute administration of grape seed proanthocyanidin extract modulates energetic metabolism in skeletal muscle and BAT mitochondria. J Agric Food Chem 2011;59:4279-4287.
30. Pajuelo D, Fernández-Iglesias A, Díaz S, et al. Improvement of mitochondrial function in muscle of genetically obese rats after chronic supplementation with proanthocyanidins. J Agric Food Chem 2011;59: 8491-8498.
31. Fitzpatrick DF, Fleming RC, Bing B, Maggi DA, O'Malley RM. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. J Agric Food Chem 2000;48:6384-6390.
32. Feringa HH, Laskey DA, Dickson JE, Coleman CI. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc 2011;111:1173-1181.
33. Drieling RL, Gardner CD, Ma J, Ahn DK, Stafford RS. No beneficial effects of pine bark extract on cardiovascular disease risk factors. Arch Intern Med 2010;170:1541-1547.
34. Peng N, Clark JT, Prasain J, Kim H, White CR, Wyss JM. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005;289:R771-R775.